论文部分内容阅读
我院自1997年以来,采用大剂量干扰素(IFNa-2b,天津华立达生物工程有限公司生产)与胸腺肽(长春市北方制药厂生产)联合治疗慢性乙型肝炎30例,疗效较好,现报道如下。1 资料和方法1.1 一般资料 共30例,男18例,女12例,年龄23～56岁,平均35.2岁;病程1～16年,平均5.6年,全部病例HBsAg、HBeAg、HBV-DNA(polymerase chain reaction,PCR法)均阳性,ALT均异常。1.2 诊断标准 病例均符合1995年5月北京第五次全国传染病寄生虫病学术会议讨论修订标准。
Our hospital since 1997, the use of high-dose interferon (IFNa-2b, Tianjin Hua Lida Biological Engineering Co., Ltd. production) and thymosin (Changchun City, North Pharmaceutical Factory) in the treatment of chronic hepatitis B in 30 cases, the effect is better, Report as follows now. 1 Materials and Methods 1.1 General Information a total of 30 cases, 18 males and 12 females, aged 23 to 56 years, mean 35.2 years; duration of 1 to 16 years, an average of 5.6 years, all cases of HBsAg, HBeAg, HBV-DNA chain reaction, PCR method) were positive, ALT are abnormal. 1.2 Diagnostic criteria Cases are in line with the Fifth National Conference on Infectious Diseases parasitic disease in Beijing in May 1995 to discuss the revised standards.